×
0 0 0 0 0 -0.0555555555555556 -0.0622222222222221 -0.0666666666666666
Stockreport

BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA [Reuters]

VERACYTE (VCYT)  More Company Research Source: Reuters
Last veracyte earnings: 2/27 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA | Reuters Reuters Staff 1 Min Read Sept 25 (Reuters) - Veracyte Inc * Veracyte Inc - reimbursement rate for Afirma Genomic Classifier is expected to increase from $3,220 to $3,600 for calendar year 2018 * Veracyte - CMS plans to finalize rates in Nov 2017, following a public comment period, and new rates are scheduled to become effective Jan. 1, 2018 Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA Sept 25 (Reuters) - Veracyte Inc * Veracyte Inc - reimbursement rate for Afirma Genomic Classifier is expected to increase from $3,220 to $3,600 for calendar year 2018 * Veracyte - CMS plans to finalize rates in Nov 2017, follo [Read more]

IMPACT SNAPSHOT EVENT TIME: VCYT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS